CD274 and non-small cell lung carcinoma: Over the last few years, PD-L1 expression, evaluated by Immunohistochemistry (IHC) has been extensively evaluated as a predictive biomarker of response to ICIs in several solid cancers such as gastric cancer, esophageal tumors, and Non-Small-Cell Lung Carcinoma (NSCLC) [83].